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Background: Left ventricular hypertrophy (LVH) is a common cardiac finding generally caused by an 
adaptation of the myocardium to increased pressure or volume load, or systemic conditions or genetic 
mutations1. Amyloidosis still remains a mysterious disease, with extremely diverse palette of symp-
toms and poor prognosis, caused by extracellular deposits of autological proteins with a fibrillar ultra-
structure and specific properties. According to anatomical and clinical criteria, it can be presented as 
systemic or localized type2. 
Case report: 61-year-old male with history of dyspnea for two years, syncope relapse and mild hyper-
tension was hospitalized. The main findings were lower voltage in ECG precordial leads, increased 
level of NT-proBNP, mild normocytic anemia, thrombocytopenia, accelerated erythrocyte sedimenta-
tion, elevated creatinine serum level and urine proteinuria. Transthoracic echocardiography showed 
LVH with restrictive diastolic pattern and typical strain finding for amyloidosis. Monoclonal gammop-
athy IgM type λ was approved by electrophoresis and immunoelectrophoresis. Abdominal CT scan 
showed appearance of paraaortic, retroperitoneal and mesenteric lymphadenopathy; lymphatic cells 
were found in the cytological punctate of the lymph node, while biopsy of fat tissue and rectal biopsy 
were negative. Heart MRI approved infiltrative heart disease, and heart biopsy deposits of amorphous 
material and Congo red staining was positive for amyloidosis. Waldenström macroglobulinemia with 
an unusual presenting of systemic amyloidosis and heart involvement was diagnosed. 
Conclusion: LVH is most common echocardiographic finding although the cause itself is not always 
easy to find. This case shows a rare example of systemic amyloidosis associated with Waldenstrom’s 
macroglobulinemia3. Modern diagnostic techniques are available with increased chance of diagnos-
ing the rare diseases, but still the most important fact is to be aware of these conditions. 
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